<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Drug Policy</journal-id><journal-id journal-id-type="iso-abbrev">Int J Drug Policy</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The International journal on drug policy</journal-title></journal-title-group><issn pub-type="ppub">0955-3959</issn><issn pub-type="epub">1873-4758</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10842406</article-id><article-id pub-id-type="pmcid-ver">PMC10842406.319</article-id><article-id pub-id-type="pmcaid">10842406</article-id><article-id pub-id-type="pmcaiid">10842406</article-id><article-id pub-id-type="manuscript-id">NIHMS1940397</article-id><article-id pub-id-type="pmid">37890392</article-id><article-id pub-id-type="doi">10.1016/j.drugpo.2023.104235</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1940397</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1940397</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Development of a Systematic Social Observation Tool for Monitoring Use of Harm Reduction Supplies</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Nesoff</surname><given-names initials="ED">Elizabeth D.</given-names></name><degrees>PhD, MPH</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aronowitz</surname><given-names initials="SV">Shoshana V.</given-names></name><degrees>PhD, MSHP, FNP-BC</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Milam</surname><given-names initials="AJ">Adam J.</given-names></name><degrees>MD, PhD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Furr-Holden</surname><given-names initials="CDM">C. Debra M.</given-names></name><degrees>PhD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib></contrib-group><aff id="A1"><label>1</label>University of Pennsylvania Perelman School of Medicine; Department of Biostatistics, Epidemiology, and Informatics; 423 Guardian Dr, Philadelphia, PA 19104, USA</aff><aff id="A2"><label>2</label>University of Pennsylvania School of Nursing; Department of Family and Community Health; 418 Curie Boulevard, Philadelphia, PA 19104, USA</aff><aff id="A3"><label>3</label>Mayo Clinic; Department of Anesthesiology and Perioperative Medicine; 5777 E. Mayo Blvd, Phoenix, AZ 85054, USA</aff><aff id="A4"><label>4</label>NYU School of Global Public Health; Department of Epidemiology; 708 Broadway, New York, NY 10003, USA</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author: Elizabeth D. Nesoff; University of Pennsylvania Perelman School of Medicine; Department of Biostatistics, Epidemiology, and Informatics; 423 Guardian Dr, Philadelphia, PA 19104, USA; <email>enesoff@upenn.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P33"><bold>Conflict of Interest</bold>: All authors have no possible conflicts of interest to disclose.</p></fn><fn fn-type="COI-statement" id="FN7"><p id="P40">Declaration of interests</p><p id="P41">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></fn></author-notes><pub-date pub-type="ppub"><month>12</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2023</year></pub-date><volume>122</volume><issue-id pub-id-type="pmc-issue-id">455061</issue-id><fpage>104235</fpage><lpage>104235</lpage><pub-history><event event-type="nihms-submitted"><date><day>29</day><month>10</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>12</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-01 00:25:14.133"><day>01</day><month>12</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1940397.pdf"/><abstract id="ABS1"><sec id="S1"><title>BACKGROUND:</title><p id="P1">Harm reduction services such as safer injection supply distribution are essential to reducing morbidity and mortality among people who use drugs (PWUD); however, local use of harm reduction supplies (e.g., tourniquets, saline solution) is difficult to routinely and systematically monitor. The purpose of this study was to develop and validate a systematic social observation tool designed to assess use of harm reduction supplies at the street block level.</p></sec><sec id="S2"><title>METHODS:</title><p id="P2">Data collection took place on a random sample of 150 blocks located throughout the Kensington neighborhood of North Philadelphia from November 2021 to January 2022. We measured inter-rater reliability by two-way mixed-effects intra-class correlation coefficients (ICC) with the consistency agreement definition and internal consistency reliability using Cronbach&#8217;s alpha and McDonald&#8217;s omega. Exploratory factor analysis with principal component extraction and promax rotation assessed internal consistency. We validated scales against locations of public syringe disposal boxes, a proxy measure for areas of concentrated drug use, using logistic regression.</p></sec><sec id="S3"><title>RESULTS:</title><p id="P3">Naloxone canisters, syringe caps, saline and sterile water solution bottles showed the highest reliability (ICC&#8805;0.7). Items also showed high internal consistency (alpha, omega&gt;0.7). Exploratory factor analysis identified one, three-item scale with high internal consistency: syringe caps, vials, and baggies (alpha=0.85; omega=0.85)&#8212;all supplies used concurrently with drug injection but not discarded in syringe disposal boxes. Drug use (OR=1.784, 95% CI=(1.48, 2.23)), harm reduction (OR=3.53, 95% CI=(2.20, 6.12)), and EFA scales (OR=1.85, 95%CI=(1.51, 2.34)) were significantly and positively associated with being within walking distance (&#8804;0.25 miles or 0.4 km) of a syringe disposal box.</p></sec><sec id="S4"><title>CONCLUSION:</title><p id="P4">This study provides an efficient tool with high reliability and validity metrics to assess community uptake of harm reduction supplies designed for use by community organizations, policy makers, or other groups providing resources to PWUD.</p></sec></abstract><kwd-group><kwd>harm reduction</kwd><kwd>naloxone</kwd><kwd>syringe</kwd><kwd>systematic social observation</kwd><kwd>neighborhood</kwd><kwd>drug use</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>